By Editor , 3 November 2026
Chemours Q3 Adjusted EBITDA Rises to $200M on TiO2 Pricing

Wilmington – November 02, 2026 -- Chemours (NYSE: CC) reported third-quarter 2026 Adjusted EBITDA of $200 million, up from $189 million a year earlier, as TiO2 price increases and growth in high-value materials for data center and semiconductor customers offset a sharp decline in refrigerants.

By Editor , 29 September 2026
Glycolic Acid Market to Hit $1.27 Trillion by 2034, Report Finds

Pune, India – September 28, 2026 -- The global glycolic acid market is projected to grow from USD 723.75 billion in 2025 to USD 1,267.06 billion by 2034, expanding at a compound annual growth rate of 6.42%, according to a new report from Maximize Market Research.

By Editor , 16 September 2026
DuPont, Chemours, Corteva Settle NC PFAS Claims for $455 Million

Wilmington, Del. – September 15, 2026 -- DuPont, together with The Chemours Company and Corteva Inc., has agreed to pay $455 million over 15 years to resolve PFAS litigation brought by the State of North Carolina and 11 local entities near the companies' Fayetteville Works facility.

By Editor , 16 September 2026
Chemours Settles NC PFAS Litigation for $455 Million Over 15 Years

Wilmington, Del. – September 15, 2026 -- The Chemours Company, along with DuPont de Nemours and Corteva, has agreed to pay $455 million over 15 years to settle PFAS-related litigation brought by the State of North Carolina and 11 local entities near the company's Fayetteville Works facility.